Estrella Immunopharma, Inc.
ESLA · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $917 | $4,165 | $41 | $4,088 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $289 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $724 | $0 | $12 | $833 |
| Total Curr. Assets | $1,641 | $4,454 | $52 | $4,922 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $9,671 | $45,187 |
| Tax Assets | $0 | $0 | $263 | $0 |
| Other NC Assets | $1,500 | $0 | $0 | $0 |
| Total NC Assets | $1,500 | $0 | $9,934 | $45,187 |
| Other Assets | $0 | $0 | $0 | -$45,187 |
| Total Assets | $3,141 | $4,454 | $9,986 | $4,922 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $47 | $946 |
| Short-Term Debt | $0 | $0 | $499 | $0 |
| Tax Payable | $0 | $45 | $51 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,997 | $136 | $9,162 | $0 |
| Total Curr. Liab. | $2,997 | $181 | $1,073 | $947 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $292 | $0 |
| Other NC Liab. | $0 | $0 | $1,550 | $5,015 |
| Total NC Liab. | $0 | $0 | $1,843 | $5,015 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,997 | $181 | $2,916 | $5,962 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $9,327 | $0 |
| Retained Earnings | -$23,927 | -$19,500 | -$2,256 | -$1,074 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $24,067 | $23,770 | $19,259 | $34 |
| Total Equity | $144 | $4,273 | $7,071 | -$1,040 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,141 | $4,454 | $9,986 | $4,922 |
| Net Debt | -$917 | -$4,165 | $458 | -$4,088 |